Apolipoprotein E1-Hammersmith (Lys146 → Asn;Arg147 → Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia
- 2 August 1996
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 124 (2) , 183-189
- https://doi.org/10.1016/0021-9150(96)05819-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Increased Hepatic Secretion of Very-Low-Density Lipoprotein Apolipoprotein B-100 in Obesity: A Stable Isotope StudyClinical Science, 1995
- Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levelsHuman Mutation, 1994
- Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.Journal of Clinical Investigation, 1991
- Apolipoprotein ECurrent Opinion in Lipidology, 1990
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- Identical Structural and Receptor Binding Defects in Apolipoprotein E2 in Hypo-, Normo-, and Hypercholesterolemic DysbetalipoproteinemiaJournal of Clinical Investigation, 1983
- Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.Journal of Clinical Investigation, 1981
- Type III Hyperlipoproteinemia: Defective Metabolism of an Abnormal Apolipoprotein EScience, 1981
- Lipid and lipoprotein distributions in white children ages 6–19 yr. The lipid research clinics program prevalence studyJournal of Chronic Diseases, 1981
- Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in manNature, 1977